ClinConnect ClinConnect Logo
Search / Trial NCT01873924

Clinical and Neuropsychological Investigations in Batten Disease

Launched by UNIVERSITY OF ROCHESTER · Jun 5, 2013

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Batten Disease Ncl Neuronal Ceroid Lipofuscinosis

ClinConnect Summary

This clinical trial is looking at Batten disease, a rare genetic condition that affects the nervous system. The main goal is to gather information about how this disease affects people's everyday abilities, including their movement, behavior, and overall functioning. Researchers will also work on improving a specific tool called the Unified Batten Disease Rating Scale (UBDRS), which helps doctors assess how the disease impacts patients.

To participate, individuals of any age who have any form of Batten disease, as well as parents or guardians of those affected, are eligible. Participants can expect to share important information about their experiences with the disease, which will help improve understanding and treatment in the future. It's important to note that parents or guardians must be willing to give permission for their participation. This study is currently recruiting participants, and everyone is welcome to take part, regardless of age or gender.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • child or adult with any form of Batten disease
  • parent or legal guardian of a child or adult with any form of Batten disease
  • Exclusion Criteria:
  • - parent or guardian unable or unwilling to provide permission for the affected individual

About University Of Rochester

The University of Rochester is a leading academic institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Renowned for its commitment to excellence in education, research, and clinical practice, the university fosters a collaborative environment that integrates cutting-edge scientific inquiry with practical applications in healthcare. With a focus on diverse therapeutic areas, the University of Rochester aims to enhance treatment options and outcomes for patients while contributing to the broader scientific community through rigorous study design and ethical standards in clinical research.

Locations

Rochester, New York, United States

Patients applied

0 patients applied

Trial Officials

Jonathan W Mink, MD PhD

Principal Investigator

University of Rochester

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials